(Q36299309)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16254457%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

review article

1 reference

title

Tumor markers in breast cancer- European Group on Tumor Markers recommendations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16254457%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16254457%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Rafael Molina

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16254457%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Vivian Barak

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16254457%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Arie van Dalen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16254457%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Michael J Duffy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16254457%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Roland Einarsson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16254457%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Helenka Goike

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16254457%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Rolf Lamerz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16254457%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Marius Nap

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16254457%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

György Sölétormos

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16254457%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Petra Stieber

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16254457%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 November 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16254457%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16254457%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16254457%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16254457%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

281-293

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16254457%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1159/000089260

8 January 2020

exact match

0 references

cites work

Global cancer statistics, 2002

1 reference

The tumour associated antigen CA15.3 in primary breast cancer. Evaluation of 667 cases

21 January 2018

1 reference

Objective measurement of therapeutic response in breast cancer using tumour markers

21 January 2018

1 reference

Utility of C-erbB-2 in tissue and in serum in the early diagnosis of recurrence in breast cancer patients: comparison with carcinoembryonic antigen and CA 15.3.

21 January 2018

1 reference

Continuous chemotherapy in responsive metastatic breast cancer: a role for tumour markers?

21 January 2018

1 reference

An evaluation of preoperative CA 15-3 measurement in primary breast carcinoma

21 January 2018

1 reference

Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients

21 January 2018

1 reference

Complete Remissions in Metastatic Breast Cancer Treated with Combination Drug Therapy

21 January 2018

1 reference

Potential for cost economies in guiding therapy in patients with metastatic breast cancer

21 January 2018

1 reference

The multifaceted mechanisms of estradiol and estrogen receptor signaling.

21 January 2018

1 reference

Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients

21 January 2018

1 reference

The ErbB signaling network: receptor heterodimerization in development and cancer

21 January 2018

1 reference

Assessment of molecular markers of clinical sensitivity to single-agent taxane therapy for metastatic breast cancer

21 January 2018

1 reference

The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy

21 January 2018

1 reference

Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1.

21 January 2018

1 reference

External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extracts

21 January 2018

1 reference

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

A molecular signature of metastasis in primary solid tumors

21 January 2018

1 reference

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference